Physician
Advanced Pain Medicine Institute, PC
Advanced Pain Medicine Institute, PC was paid $1.52M by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 51% of everything it billed.
33Billing provider infoADVANCED PAIN MEDICINE INSTITUTE, PC
GREENBELT, MD 20770
GREENBELT, MD 20770
33aNPI1144310921assigned 10/13/2006
33bProvider typeAnesthesiology Physician
28Total paid$1.52M
24GClaims30,310
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anesthesiology Physician providers in Maryland
Rank by total paid#1 of 59
Median peer was paid$4K
This provider vs. median338×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,312 | $79K | |
| 2019 | 867 | $47K | |
| 2020 | 3,747 | $193K | |
| 2021 | 7,227 | $460K | |
| 2022 | 4,787 | $280K | |
| 2023 | 6,543 | $235K | |
| 2024incomplete | 5,827 | $222K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 51% | 14,491 | 11,161 | $778K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 17% | 2,206 | 1,828 | $258K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.9% | 1,657 | 1,421 | $150K |
| 64483 | 6.5% | 1,571 | 1,110 | $99K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.0% | 979 | 772 | $46K |
| 01992 | 2.7% | 854 | 646 | $41K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.6% | 1,169 | 361 | $40K |
| 80305 | 2.2% | 4,150 | 3,139 | $34K | |
| 64484 | <1% | 379 | 278 | $12K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 131 | 86 | $10K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 611 | 191 | $9K |
| 01938 | <1% | 204 | 154 | $8K |
26 more codes
| 62321 | <1% | 90 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 59 | $4K |
| 64635 | <1% | 17 | $4K | |
| J2704 | Injection, propofol, 10 mg | <1% | 454 | $3K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 73 | $3K |
| 64636 | <1% | 33 | $2K | |
| 93923 | <1% | 15 | $2K | |
| 97014 | <1% | 31 | $1K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 41 | $1K |
| 82670 | <1% | 41 | $1K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 128 | $941.99 |
| 82627 | <1% | 41 | $894.62 | |
| 97162 | <1% | 16 | $775.46 | |
| 82533 | <1% | 41 | $656.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 60 | $615.17 |
| 82607 | <1% | 41 | $606.39 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 80 | $600.87 |
| 80061 | Lipid panel | <1% | 41 | $538.74 |
| 84439 | <1% | 108 | $522.59 | |
| 80050 | General health panel | <1% | 63 | $506.25 |
| 83735 | <1% | 84 | $407.67 | |
| 84481 | <1% | 42 | $350.06 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 237 | $154.38 |
| 97012 | <1% | 20 | $140.62 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 39 | $33.00 |
| 01937 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGHORBANI, REZA (PRACTICE MANANGEMENT, PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Advanced Pain Medicine Institute | Greenbelt, MD | $1.21M |
| Surgcenter of Greenbelt, LLC | Greenbelt, MD | $68K |
| Advanced Pain Medicine Institute, PC | Chevy Chase, MD | $8K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.